Anterix Inc.
ATEX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 9.4% | 2.1% | -11.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 3,909.5% | 1,585.4% | 676.5% | 449% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | -$0 | $0 | -$0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 3,449.5% | 1,775.7% | 662.9% | 492.3% |
| EPS | 2.86 | 1.35 | 0.5 | 0.41 |
| % Growth | 111.9% | 170% | 22% | – |
| EPS Diluted | 2.86 | 1.35 | 0.49 | 0.41 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 3,942.5% | -821.2% | -756.9% | -642.8% |